provision and use of services and implementation of strategies. From option A, the PMTCT moved to option B, then to option B+ which is an ARV treatment for life of HIV positive pregnant women in a bid to improve their survival and that of their children. Exceeding the projected targets in the PNDS is due to the extension of PTMCT sites, the coverage of which is currently 80%; the acceptance of the screening by women, the acceptable availability of inputs (tests and ARVs) and the organisation of PTMCT sites has brought into being the ARVs in the absence of the CD4 count. The following Chart presents access by women and children to ARVs. Chart No. 9: Trend of the rate of HIV- positive pregnant women having received ARVs to reduce mother-to-child transmission (MCT) of HIV Evolution du taux de femmes enceintes séropositives ayant reçu les ARV pour réduire la TME du VIH 100.0% 80.0% 60.0% 40.0% 20.0% 0.0% 87.4% 68.2% 68.0% 2012 90.7% 75.1% 72.0% 2013 75.0% 80.5% Cibles Réalisés 2014 2015 Source: PNLS Annual Activity Reports PNLS 217. Apart from the successes achieved, some bottlenecks have to be addressed, particularly the low notification rate of infants exposed to the virus (59% in 2014), lack of monitoring of both mother and child, the low rate of access to biological monitoring assessments of women, the low decewntralisation in the supply of inputs up to the district level, leading to disruptions on sites with available stock at the central level and finally the rate of transmission from mother to child which is still high at 14.7% at 18 months of age. 5.5-Tuberculosis 218. At the end of 2012, the LNR launched the Genexpert which allows a quick diagnosis of the resistance of rifampicine in less than 2 hours. The experimental protocol of 9 months of the UNION is the one applied in Togo. Moreover, 16 cases of Multi-Drug-Resistant TB were identified in 2013. 67